SCHEMBL31455145

SCHEMBL31455145

COC(=O)C1CC2(CC(C(=O)Nc3ccc(Nc4nc(-c5ccccc5)ccc4[N+](=O)[O-])c(C)c3F)C2)C1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
ABCB1 P08183 6/20 0.33
NPC1 O15118 2/20 0.33
GSK3A P49840 1/20 0.33
GSK3B P49841 1/20 0.33
ABCC1 P33527 4/20 0.32
WDR5 P61964 1/20 0.32
HDAC1 Q13547 1/20 0.31
HDAC2 Q92769 1/20 0.31
ADORA3 P0DMS8 1/20 0.31
ADORA2A P29274 1/20 0.31
ADORA1 P30542 1/20 0.31
MEN1 O00255 2/20 0.30
KMT2A Q03164 2/20 0.30
RAB9A P51151 2/20 0.30
L3MBTL1 Q9Y468 2/20 0.30
P2RX7 Q99572 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31455449 0.91 GSK3B (0.39) CYP3A4CYP2C9CYP2C19NPSR1ABCB1
SCHEMBL31455406 0.88 CYP3A4 (0.34) CYP3A4CYP2C9CYP2C19NPSR1ABCB1
SCHEMBL31455019 0.87 GSK3A (0.34) CYP3A4CYP2C9CYP2C19NPSR1ABCB1
SCHEMBL31455141 0.87 POLB (0.36) ABCB1NPC1ABCC1MEN1KMT2A
SCHEMBL31455285 0.87 HDAC2 (0.40) GSK3AGSK3BHDAC1HDAC2ADORA3
SCHEMBL31455294 0.78 BRD9 (0.41) NPC1WDR5MEN1KMT2ARAB9A
SCHEMBL31455361 0.78 ADORA1 (0.40) NPC1GSK3AGSK3BADORA3ADORA2A
SCHEMBL31455694 0.77 HDAC1 (0.46) GSK3AGSK3BHDAC1HDAC2ADORA3
SCHEMBL31455411 0.77 HDAC1 (0.46) GSK3AGSK3BHDAC1HDAC2ADORA3
SCHEMBL31455204 0.76 GSK3B (0.38) ABCB1NPC1GSK3AGSK3BADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059577-A1 SUBSTITUTED AMINOPYRIDINE COMPOUNDS FOR USE AS AKT1 INHIBITORS ATAVISTIK BIO, INC. (US) 2025-03-20 WO disclosed